MAHONEY DAVID L 4
4 · CORCEPT THERAPEUTICS INC · Filed Apr 12, 2024
Insider Transaction Report
Form 4
MAHONEY DAVID L
Director
Transactions
- Exercise/Conversion
Common Stock
2024-04-10$1.74/sh+30,000$52,200→ 30,000 total - Other
Common Stock
2024-04-10−27,806→ 27,806 total - Tax Payment
Common Stock
2024-04-10$23.80/sh−2,194$52,217→ 27,806 total - Other
Common Stock
2024-04-10+27,806→ 1,212,614 total(indirect: By Trust) - Exercise/Conversion
Stock option (right to buy)
2024-04-10−30,000→ 0 totalExercise: $1.74Exp: 2024-05-08→ Common Stock (30,000 underlying)
Holdings
- 46,147(indirect: By Foundation)
Common Stock
Footnotes (4)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on April 10, 2024. The options subject to the net exercise were to expire on May 8, 2024.
- [F2]Transfer of shares without consideration to the David L. Mahoney and Winnifred C. Ellis 1998 Family Trust.
- [F3]The Form 4 previously filed inadvertently overstated the number of shares held by 15,000. The number in Column 5 reflects the corrected amount.
- [F4]Fully exercisable.